Adrenodoxin-A versatile ferredoxin

IUBMB Life

Volumn 64, Issue 6, 2012, Pages 506-512

  Ewen, Kerstin Maria ^a   Ringle, Michael ^a   Bernhardt, Rita ^a  

^a SAARLAND UNIVERSITY   (Germany)

Author keywords

adrenodoxin; biotechnology; cytochrome P450 system; ferredoxin; redox partner; whole cell bioconversion

Indexed keywords

ADRENODOXIN; CYTOCHROME P450;

BIOTECHNOLOGY; CATALYSIS; CHEMICAL REACTION; CONTROLLED STUDY; DRUG INDUSTRY; DRUG SCREENING; DRUG TARGETING; NONHUMAN; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS; REVIEW; SENSITIVITY ANALYSIS;

ADRENODOXIN; ANIMALS; BACTERIAL PROTEINS; COENZYMES; CYTOCHROME P-450 ENZYME SYSTEM; DRUG EVALUATION, PRECLINICAL; FERREDOXINS; HUMANS; MITOCHONDRIA; OXIDATION-REDUCTION; RECOMBINANT PROTEINS;

BACTERIA (MICROORGANISMS); MAMMALIA;

EID: 84861303750     PISSN: 15216543     EISSN: 15216551     Source Type: Journal    
DOI: 10.1002/iub.1029     Document Type: Review

References (54)

1. Wächtershäuser, G., (1992) Groundworks for an evolutionary biochemistry: the iron-sulphur world. Prog. Biophys. Mol. Biol. 58, 85-201.
2. Hannemann, F., Bichet, A., Ewen, K. M., and, Bernhardt, R., (2007) Cytochrome P450 systems-biological variations of electron transport chains. Biochim. Biophys. Acta 1770, 330-344.
3. Bernhardt, R., and, Waterman, M. R., (2007) Cytochrome P450 and steroid hormone biosynthesis. In: The Ubiquitous Roles of Cytochrome P450 Proteins, Vol. 3 (, Sigel, A., Sigel, H., and, Sigel, R. K. O., eds.). pp. 361-396, John Wiley & Sons, Ltd, Chichester, UK.
4. Coghlan, V. M., and, Vickery, L. E., (1991) Site-specific mutations in human ferredoxin that affect binding to ferredoxin reductase and cytochrome P450scc. J. Biol. Chem. 266, 18606-18612.
5. Strushkevich, N., MacKenzie, F., Cherkesova, T., Grabovec, I., Usanov, S., et al. (2011) Structural basis for pregnenolone biosynthesis by the mitochondrial monooxygenase system. Proc. Natl. Acad. Sci. USA 108, 10139-10143.
6. Berg, A., Gustafsson, J.A., and Ingelman-, Sundberg, M., (1976) characterization of a cytochrome P-450-dependent steroid hydroxylase system present in Bacillus megaterium. J Biol. Chem. 251, 2831-2838.
7. Beckert, V., Dettmer, R., and, Bernhardt, R., (1994) Mutations of tyrosine 82 in bovine adrenodoxin that affect binding to cytochromes P45011A1 and P45011B1 but not electron transfer. J. Biol. Chem. 269, 2568-2573.
8. Sakaki, T., Kagawa, N., Yamamoto, K., and, Inouye, K., (2005) Metabolism of vitamin D3 by cytochromes P450. Front. Biosci. 10, 119-134.
9. Schuster, I., (2011) Cytochromes P450 are essential players in the vitamin D signaling system. Biochim. Biophy. Acta Protein Proteomics 1814, 186-199.
10. Anandatheerthavarada, H. K., Addya, S., Mullick, J., and, Avadhani, N. G., (1998) Interaction of adrenodoxin with P4501A1 and its truncated form P450MT2 through different domains: differential modulation of enzyme activities. Biochemistry 37, 1150-1160.
11. Lehnerer, M., Schulze, J., Bernhardt, R., and, Hlavica, P., (1999) Some properties of mitochondrial adrenodoxin associated with its nonconventional electron donor function toward rabbit liver microsomal cytochrome P450 2B4. Biochem. Biophy. Res. Commun. 254, 83-87.
12. Liao, W. L., Dodder, N. G., Mast, N., Pikuleva, I. A., and, Turko, I. V., (2009) Steroid and protein ligand binding to cytochrome P450 46A1 as assessed by hydrogen-deuterium exchange and mass spectrometry. Biochemistry 48, 4150-4158.
13. Pechurskaya, T. A., Harnastai, I. N., Grabovec, I. P., Gilep, A. A., and, Usanov, S. A., (2007) Adrenodoxin supports reactions catalyzed by microsomal steroidogenic cytochrome P450s. Biochem. Biophys. Res. Commun. 353, 598-604.
14. Lill, R., (2009) Function and biogenesis of iron-sulphur proteins. Nature 460, 831-838.
15. Sheftel, A. D., Stehling, O., Pierik, A. J., Elsässer, H. P., Mühlenhoff, U., et al. (2010) Humans possess two mitochondrial ferredoxins, Fdx1 and Fdx2, with distinct roles in steroidogenesis, heme, and Fe/S cluster biosynthesis. Proc. Natl. Acad. Sci. USA 107, 11775-11780.
16. Shi, Y., Ghosh, M., Kovtunovych, G., Crooks, D. R., and, Rouault, T. A., (2011) Both human ferredoxins 1 and 2 and ferredoxin reductase are important for iron-sulfur cluster biogenesis. Biochim. Biophys. Acta 1823, 484-492.
17. Hakki, T., and, Bernhardt, R., (2006) CYP17- and CYP11B-dependent steroid hydroxylases as drug development targets. Pharmacol. Ther 111, 27-52.
18. Hakki, T., Hubel, K., Waldmann, H., and, Bernhardt, R., (2011) The development of a whole-cell based medium throughput screening system for the discovery of human aldosterone synthase (CYP11B2) inhibitors: old drugs disclose new applications for the therapy of congestive heart failure, myocardial fibrosis and hypertension. J. Steroid Biochem. Mol. Biol. 125, 120-128.
19. Bureik, M., Schiffler, B., Hiraoka, Y., Vogel, F., and, Bernhardt, R., (2002) Functional expression of human mitochondrial CYP11B2 in fission yeast and identification of a new internal electron transfer protein, etp1. Biochemistry 41, 2311-2321.
20. Schiffler, B., Bureik, M., Reinle, W., Müller, E. C., Hannemann, F., et al. (2004) The adrenodoxin-like ferredoxin of Schizosaccharomyces pombe mitochondria. J. Inorg. Biochem. 98, 1229-1237.
21. Virus, C., Lisurek, M., Simgen, B., Hannemann, F., and, Bernhardt, R., (2006) Function and engineering of the 15beta-hydroxylase CYP106A2. Biochem. Soc. Trans. 34, 1215-1218.
22. Hakki, T., Zearo, S., Dragan, C. A., Bureik, M., and, Bernhardt, R., (2008) Coexpression of redox partners increases the hydrocortisone (cortisol) production efficiency in CYP11B1 expressing fission yeast Schizosaccharomyces pombe. J. Biotechnol. 133, 351-359.
23. LaSala, D., Shibanaka, Y., and, Jeng, A. Y., (2009) Coexpression of CYP11B2 or CYP11B1 with adrenodoxin and adrenodoxin reductase for assessing the potency and selectivity of aldosterone synthase inhibitors. Anal. Biochem. 394, 56-61.
24. Nelson, D. R., (2011) Progress in tracing the evolutionary paths of cytochrome P450. Biochim. Biophys. Acta 1814, 14-18.
25. Bernhardt, R., (2006) Cytochromes P450 as versatile biocatalysts. J. Biotechnol. 124, 128-145.
26. Schiffler, B., and, Bernhardt, R., (2003) Bacterial (CYP101) and mitochondrial P450 systems-how comparable are they? Biochem. Biophys. Res. Commun. 312, 223-228.
27. Girhard, M., Klaus, T., Khatri, Y., Bernhardt, R., and, Urlacher, V., B. (2010) Characterization of the versatile monooxygenase CYP109B1 from Bacillus subtilis. Appl. Microbiol. Biotechnol. 87, 595-607.
28. Khatri, Y., Hannemann, F., Ewen, K.M., Pistorius, D., Perlova, O., et al. (2010) The CYPome of Sorangium cellulosum So ce56 and identification of CYP109D1 as a new fatty acid hydroxylase. Chem. Biol. 17, 1295-1305.
29. Khatri, Y., Girhard, M., Romankiewicz, A., Ringle, M., Hannemann, F., et al. (2010) Regioselective hydroxylation of norisoprenoids by CYP109D1 from Sorangium cellulosum So ce56. Appl. Microbiol. Biotechnol. 88, 485-495.
30. Ly, T. T. B., Khatri, Y., Zapp, J., Hutter, M. C., and, Bernhardt, R., (2012) CYP264B1 from Sorangium cellulosum So ce56: a fascinating norisoprenoid and sesquiterpene hydroxylase. Appl. Microbiol. Biotechnol. [Epub ahead of print]. DOI: 10.1007/s00253-011-3727-z.
31. Girhard, M., Machida, K., Itoh, M., Schmid, R.D., Arisawa, A., et al. (2009) Regioselective biooxidation of (+)-valencene by recombinant E. coli expressing CYP109B1 from Bacillus subtilis in a two-liquid-phase system. Microb. Cell Fact. 8: 36.
32. Bleif, S., Hannemann, F., Lisurek, M., von Kries, J. P., Zapp, J., et al. (2011) Identification of CYP106A2 as a regioselective allylic bacterial diterpene hydroxylase. Chembiochem 12, 576-582.
33. Lisurek, M., Kang, M. J., Hartmann, R. W., and, Bernhardt, R., (2004) Identification of monohydroxy progesterones produced by CYP106A2 using comparative HPLC and electrospray ionisation collision-induced dissociation mass spectrometry. Biochem. Biophys. Res. Commun. 319, 677-682.
34. Zehentgruber, D., Hannemann, F., Bleif, S., Bernhardt, R., and, Lütz, S., (2010) Towards preparative scale steroid hydroxylation with cytochrome P450 monooxygenase CYP106A2. Chembiochem 11, 713-721.
35. Agematu, H., Matsumoto, N., Fujii, Y., Kabumoto, H., Doi, S., Machida, K., Ishikawa, J., and, Arisawa, A., (2006) Hydroxylation of testosterone by bacterial cytochromes P450 using the Escherichia coli expression system. Biosci. Biotechnol. Biochem. 70, 307-311.
36. Hannemann, F., Virus, C., and, Bernhardt, R., (2006) Design of an Escherichia coli system for whole cell mediated steroid synthesis and molecular evolution of steroid hydroxylases. J. Biotechnol. 25, 25.
37. Virus, C., Lisurek, M., Simgen, B., Hannemann, F., and, Bernhardt, R., (2006) Function and engineering of the 15beta-hydroxylase CYP106A2. Biochem. Soc. Trans. 34, 1215-1218.
38. Berg, A., Gustafsson, J. A., and, Ingelman-Sundberg, M., (1976) Characterization of a cytochrome P-450-dependent steroid hydroxylase system present in Bacillus megaterium. J Biol. Chem. 251, 2831-2838.
39. Bleif, S., Hannemann, F., Zapp, J., Hartmann, D., Jauch, J., et al. (2011) A new Bacillus megaterium whole-cell catalyst for the hydroxylation of the pentacyclic triterpene 11-keto-beta-boswellic acid (KBA) based on a recombinant cytochrome P450 system. Appl. Microbiol. Biotechnol. 93, 1135-1146.
40. Schmitz, D., Zapp, J., and, Bernhardt, R., Hydroxylation of the dammarane triterpenoid dipterocarpol with CYP106A2 from Bacillus megaterium ATCC 13368. FEBS J., in press.
41. Ogura, H., Nishida, C. R., Hoch, U. R., Perera, R., Dawson, J. H., et al. (2004) EpoK, a cytochrome P450 involved in biosynthesis of the anticancer agents epothilones A and B. Substrate-mediated rescue of a P450 enzyme. Biochemistry 43, 14712-14721.
42. Uhlmann, H., Kraft, R., and, Bernhardt, R., (1994) C-terminal region of adrenodoxin affects its structural integrity and determines differences in its electron transfer function to cytochrome P-450. J. Biol. Chem. 269, 22557-22564.
43. Grinberg, A. V., Hannemann, F., Schiffler, B., Müller, J., Heinemann, U., et al. (2000) Adrenodoxin: structure, stability, and electron transfer properties. Proteins 40, 590-612.
44. Sagara, Y., Wada, A., Takata, Y., Waterman, M. R., Sekimizu, K., et al. (1993) Direct expression of adrenodoxin reductase in Escherichia coli and the functional characterization. Biol. Pharm. Bull. 16, 627-630.
45. Schiffler, B., Zöllner, A., and, Bernhardt, R., (2004) Stripping down the mitochondrial cholesterol hydroxylase system, a kinetics study. J. Biol. Chem. 279, 34269-34276.
46. Fischer, F., Raimondi, D., Aliverti, A., and, Zanetti, G., (2002) Mycobacterium tuberculosis FprA, a novel bacterial NADPH-ferredoxin reductase. Eur. J. Biochem. 269, 3005-3013.
47. Faro, M., Schiffler, B., Heinz, A., Nogues, I., Medina, M., et al. (2003) Insights into the design of a hybrid system between Anabaena ferredoxin-NADP+ reductase and bovine adrenodoxin. Eur. J. Biochem. 270, 726-735.
48. Chu, J. W., and, Kimura, T., (1973) Studies on adrenal steroid hydroxylases. Molecular and catalytic properties of adrenodoxin reductase (a flavoprotein). J. Biol. Chem. 248, 2089-2094.
49. Bichet, A., Hannemann, F., Rekowski, M., and, Bernhardt, R., (2007) A new application of the yeast two-hybrid system in protein engineering. Protein Eng. Des. Sel. 20, 117-123.
50. Jin, W., Wollenberger, U., Bernhardt, R., Stöcklein, W. F. M., and, Scheller, F. W., (1998) Direct electron transfer of adrenodoxin-a [2Fe-2S] protein-and its mutants at modified gold electrode. Bioelectrochem. Bioenerg. 47, 75-79.
51. Johnson, D., Norman, S., Tuckey, R. C., and, Martin, L. L., (2003) Electrochemical behaviour of human adrenodoxin on a pyrolytic graphite electrode. Bioelectrochemistry 59, 41-47.
52. Urlacher, V. B., and, Eiben, S., (2006) Cytochrome P450 monooxygenases: perspectives for synthetic application. Trends Biotechnol. 24, 324-330.
53. Urlacher, V. B., and, Girhard, M., (2012) Cytochrsome P450 monooxygenases: an update on perspectives for synthetic application. Trends Biotechnol. 30, 26-36.
54. Salamanca-Pinzõn, S. G., and, Guengerich, F. P., (2011) A tricistronic human adrenodoxin reductase-adrenodoxin-cytochrome P450 27A1 vector system for substrate hydroxylation in Escherichia coli. Protein Expr Purif. 79, 231-236.